Advertisement
Screener

Avantor, Inc. (AVTR) Income Taxes Paid

1.9 / 5 stars · 29/75 Roast Me

Avantor, Inc. Income Taxes Paid

Avantor, Inc. (AVTR) reported Income Taxes Paid of $10.40 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:IncomeTaxesPaidNet · last filed 2026-04-29

  • Avantor, Inc. income taxes paid, net for the quarter ending 2026-03-31 was $10.40M, a 37.72% decline year-over-year.
  • Avantor, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $29.30M, a 75.52% decline year-over-year.
  • Avantor, Inc. income taxes paid, net for the quarter ending 2025-09-30 was $21.90M, a 47.36% decline year-over-year.
  • Avantor, Inc. income taxes paid, net for the quarter ending 2025-06-30 was $77.10M, a 11.10% increase year-over-year.
  • Avantor, Inc. income taxes paid, net for fiscal 2025 was $145.00M, a 41.49% decline from fiscal 2024.
  • Avantor, Inc. income taxes paid, net for fiscal 2024 was $247.80M, a 10.43% increase from fiscal 2023.
  • Avantor, Inc. income taxes paid, net for fiscal 2023 was $224.40M, a 12.65% decline from fiscal 2022.
  • Avantor, Inc. income taxes paid, net for fiscal 2022 was $256.90M, a 77.54% increase from fiscal 2021.
Period endIncome Taxes Paid, Net 3 monthIncome Taxes Paid, Net 6 monthIncome Taxes Paid, Net 9 monthIncome Taxes Paid, Net 12 month
2026-03-31$10.40M
10-Q · filed 2026-04-29
$39.70M
derived: sum of 2 quarters · filed 2026-04-29
$61.60M
derived: sum of 3 quarters · filed 2026-04-29
$138.70M
derived: sum of 4 quarters · filed 2026-04-29
2025-12-31$29.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$51.20M
derived: sum of 2 quarters · filed 2026-02-11
$128.30M
derived: sum of 3 quarters · filed 2026-02-11
$145.00M
10-K · filed 2026-02-11
2025-09-30$21.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$99.00M
derived: sum of 2 quarters · filed 2025-10-29
$115.70M
10-Q · filed 2025-10-29
$235.40M
derived: sum of 4 quarters · filed 2026-04-29
2025-06-30$77.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01
$93.80M
10-Q · filed 2025-08-01
$213.50M
derived: sum of 3 quarters · filed 2026-04-29
$255.10M
derived: sum of 4 quarters · filed 2026-04-29
2025-03-31$16.70M
10-Q · filed 2026-04-29
$136.40M
derived: sum of 2 quarters · filed 2026-04-29
$178.00M
derived: sum of 3 quarters · filed 2026-04-29
$247.40M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31$119.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$161.30M
derived: sum of 2 quarters · filed 2026-02-11
$230.70M
derived: sum of 3 quarters · filed 2026-02-11
$247.80M
10-K · filed 2026-02-11
2024-09-30$41.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$111.00M
derived: sum of 2 quarters · filed 2025-10-29
$128.10M
10-Q · filed 2025-10-29
$157.20M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$69.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01
$86.50M
10-Q · filed 2025-08-01
$115.60M
derived: sum of 3 quarters · filed 2026-02-11
$184.20M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31$17.10M
10-Q · filed 2025-04-25
$46.20M
derived: sum of 2 quarters · filed 2026-02-11
$114.80M
derived: sum of 3 quarters · filed 2026-02-11
$227.90M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$29.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$97.70M
derived: sum of 2 quarters · filed 2026-02-11
$210.80M
derived: sum of 3 quarters · filed 2026-02-11
$224.40M
10-K · filed 2026-02-11
2023-09-30$68.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25
$181.70M
derived: sum of 2 quarters · filed 2024-10-25
$195.30M
10-Q · filed 2024-10-25
$269.90M
derived: sum of 4 quarters · filed 2025-02-07
2023-06-30$113.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26
$126.70M
10-Q · filed 2024-07-26
$201.30M
derived: sum of 3 quarters · filed 2025-02-07
$252.30M
derived: sum of 4 quarters · filed 2025-02-07
2023-03-31$13.60M
10-Q · filed 2024-04-26
$88.20M
derived: sum of 2 quarters · filed 2025-02-07
$139.20M
derived: sum of 3 quarters · filed 2025-02-07
$222.90M
derived: sum of 4 quarters · filed 2025-02-07
2022-12-31$74.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07
$125.60M
derived: sum of 2 quarters · filed 2025-02-07
$209.30M
derived: sum of 3 quarters · filed 2025-02-07
$256.90M
10-K · filed 2025-02-07
2022-09-30$51.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27
$134.70M
derived: sum of 2 quarters · filed 2023-10-27
$182.30M
10-Q · filed 2023-10-27
$196.80M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$83.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28
$131.30M
10-Q · filed 2023-07-28
$145.80M
derived: sum of 3 quarters · filed 2024-02-14
$206.50M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$47.60M
10-Q · filed 2023-04-28
$62.10M
derived: sum of 2 quarters · filed 2024-02-14
$122.80M
derived: sum of 3 quarters · filed 2024-02-14
$179.70M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$14.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$75.20M
derived: sum of 2 quarters · filed 2024-02-14
$132.10M
derived: sum of 3 quarters · filed 2024-02-14
$144.70M
10-K · filed 2024-02-14
2021-09-30$60.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
$117.60M
derived: sum of 2 quarters · filed 2022-10-28
$130.20M
10-Q · filed 2022-10-28
$140.90M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30$56.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29
$69.50M
10-Q · filed 2022-07-29
$80.20M
derived: sum of 3 quarters · filed 2023-02-14
$86.70M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31$12.60M
10-Q · filed 2022-04-29
$23.30M
derived: sum of 2 quarters · filed 2023-02-14
$29.80M
derived: sum of 3 quarters · filed 2023-02-14
$43.10M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31$10.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
$17.20M
derived: sum of 2 quarters · filed 2023-02-14
$30.50M
derived: sum of 3 quarters · filed 2023-02-14
$42.70M
10-K · filed 2023-02-14
2020-09-30$6.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29
$19.80M
derived: sum of 2 quarters · filed 2021-10-29
$32.00M
10-Q · filed 2021-10-29
$44.10M
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$13.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$25.50M
10-Q · filed 2021-07-30
$37.60M
derived: sum of 3 quarters · filed 2022-02-11
$77.30M
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31$12.20M
10-Q · filed 2021-04-28
$24.30M
derived: sum of 2 quarters · filed 2022-02-11
$64.00M
derived: sum of 3 quarters · filed 2022-02-11
$104.80M
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31$12.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11
$51.80M
derived: sum of 2 quarters · filed 2022-02-11
$92.60M
derived: sum of 3 quarters · filed 2022-02-11
$112.30M
10-K · filed 2022-02-11
2019-09-30$39.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27
$80.50M
derived: sum of 2 quarters · filed 2020-10-27
$100.20M
10-Q · filed 2020-10-27
$115.90M
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30$40.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
$60.50M
10-Q · filed 2020-07-29
$76.20M
derived: sum of 3 quarters · filed 2021-02-16
$89.20M
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$19.70M
10-Q · filed 2020-04-29
$35.40M
derived: sum of 2 quarters · filed 2021-02-16
$48.40M
derived: sum of 3 quarters · filed 2021-02-16
2018-12-31$15.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$28.70M
derived: sum of 2 quarters · filed 2021-02-16
$65.60M
10-K · filed 2021-02-16
2018-09-30$13.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$49.90M
10-Q · filed 2019-11-05
2018-06-30$36.90M
10-Q · filed 2019-08-06
2017-12-31$31.50M
10-K · filed 2020-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRUKER CORP (BRKR)United States$9.706B-128.75
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34